Planet 13 Holdings (PLNH) Shares Outstanding (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Shares Outstanding (Entity) of $328.3 million for Q1 2026, up 0.92% year-over-year from $325.3 million in Q1 2025, and up 0.8% quarter-over-quarter from $325.7 million in Q4 2025.
Planet 13 Holdings (PLNH) Shares Outstanding (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Shares Outstanding (Entity) for 7 consecutive years, with $328.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 0.92% year-over-year to $328.3 million; the TTM figure through Mar 2026 stood at $328.3 million (up 0.92% YoY), while the FY2025 annual figure was $325.7 million, changed 0.16% from the prior year.
- Shares Outstanding (Entity) climbed to $328.3 million in Q1 2026 per PLNH's latest filing, from $325.7 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $328.3 million in Q1 2026 and bottomed at $205.6 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $270.6 million across 5 years, with a median of $243.3 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) surged 46.31% — and 2025, when it increased 0.06%.
- Planet 13 Holdings' Shares Outstanding (Entity) stood at $216.6 million in 2022, then rose by 3.11% to $223.3 million in 2023, then soared by 45.61% to $325.2 million in 2024, then increased by 0.16% to $325.7 million in 2025, then advanced by 0.8% to $328.3 million in 2026.
- Business Quant data shows PLNH's Shares Outstanding (Entity) at $328.3 million in Q1 2026, $325.7 million in Q4 2025, and $325.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Planet 13 Holdings | 50.16 Mn | 33.68 Mn | 12.32 Mn | 330.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 327.92 Mn |
| Mar 31, 2026 | 327.92 Mn |
| Dec 31, 2025 | 325.34 Mn |
| Sep 30, 2025 | 325.36 Mn |
| Jun 30, 2025 | 325.36 Mn |
| Mar 31, 2025 | 325.26 Mn |
| Dec 31, 2024 | 292.17 Mn |
| Sep 30, 2024 | 325.16 Mn |
| Jun 30, 2024 | 289.18 Mn |
| Mar 31, 2024 | 228.44 Mn |
| Dec 31, 2023 | 221.96 Mn |
| Sep 30, 2023 | 222.08 Mn |
| Jun 30, 2023 | 221.79 Mn |
| Mar 31, 2023 | 221.08 Mn |
| Dec 31, 2022 | 216.59 Mn |
| Sep 30, 2022 | 220.15 Mn |
| Jun 30, 2022 | 220.09 Mn |
| Mar 31, 2022 | 205.57 Mn |
| Dec 31, 2021 | 195.13 Mn |
| Sep 30, 2021 | 196.29 Mn |